Colorectal Cancer in Young Adults
A distressing trend in 2026 is the continued rise of Early-Onset Colorectal Cancer (EO-CRC) in patients under 50. This has led to the universal lowering of screening ages to 45 (and in some high-risk regions, 40). Surgeries for these younger patients often focus more heavily on fertility preservation and long-term functional outcomes.
Younger patients often present with more aggressive tumor biology, necessitating a more intensive multidisciplinary approach. In 2026, every young-onset patient undergoes Germline Genetic Testing to check for Lynch Syndrome or other hereditary factors. This ensures that the surgical plan (e.g., removing a larger section of the colon to prevent future cancers) is tailored to their specific genetic risk profile.
1 View

